Swain RN, Pattanaik S, Jain A, Wadhera S, et al. Comparable response rates of venetoclax 50 mg with posaconazole versus venetoclax 400 mg despite lower pharmacokinetic exposure in newly diagnosed acute myeloid leukemia: less is enough. Leuk Lymphoma 2025 Jun 22:1-5. doi: 10.1080/10428194.2025.2519921.
PMID: 40544352